| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8769178 | Actas Urológicas Españolas | 2017 | 7 Pages |
Abstract
Adjuvant bacillus Calmette-Guérin signiï¬cantly reduces the risk of recurrence, as does switch to mTOR inhibitors. Multiple tumors increase the risk.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
O. Rodriguez Faba, J. Palou, H. Vila Reyes, L. Guirado, A. Palazzetti, P. Gontero, F. Vigués, J. Garcia-Olaverri, J.M. Fernández Gómez, J. Olsburg, C. Terrone, A. Figueiredo, J. Burgos, E. Lledó, A. Breda,